Bain Capital Life Sciences Investors, LLC Q3 2019 Filing
Filed November 14, 2019
Portfolio Value
$388.4B
Holdings
7
Report Date
Q3 2019
Filing Type
13F-HR
All Holdings (7 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SWTXSPRINGWORKS THERAPEUTICS INC | 7,281,307 | $157.9B | 40.64% | |
| 2 | —DICERNA PHARMACEUTICALS INC | 7,330,237 | $105.3B | 27.10% | |
| 3 | SLDBSOLID BIOSCIENCES INC | 3,871,164 | $40.0B | 10.31% | |
| 4 | REPLREPLIMUNE GROUP INC | 2,838,968 | $39.5B | 10.16% | |
| 5 | DVAXDYNAVAX TECHNOLOGIES CORP | 8,452,235 | $30.3B | 7.79% | |
| 6 | —MARINUS PHARMACEUTICALS INC | 5,042,735 | $7.8B | 2.00% | |
| 7 | —APTINYX INC | 2,225,092 | $7.8B | 2.00% |